论文信息 - Sorafenib (Nexavar) induces molecular remission and regression of extramedullary disease in a patient with FLT3-ITD+ acute myeloid leukemia. - 字舞流文

Sorafenib (Nexavar) induces molecular remission and regression of extramedullary disease in a patient with FLT3-ITD+ acute myeloid leukemia.

I. Bruns | G. Kobbe | R. Fenk | R. Haas | A. Czibere | A. Dienst | P. Reinecke | N. N. Safaian | A. Czibere | Nancy Safaian | Ariane Dienst